Nat. Rev. Endocrinol. doi: /nrendo

Slides:



Advertisements
Similar presentations
G Linked Receptors (Continued…….). Serine/Threonine Protein Phosphatases Rapidly Reverse the Effects of A-Kinase.
Advertisements

Hormones that affect energy metabolism © Michael Palmer 2014.
BIOC DR. TISCHLER LECTURE 22 SIGNAL TRANSDUCTION: G-PROTEINS.
Channel-linked Receptors aka: ligand-gated channels a receptor type seen in synaptic transmission rapid response (ms) limited response –depolarization.
Cell Signaling (BIO-203) Lecture 5. Signal amplification occurs in many signaling pathways Receptors are low abundance proteins The binding of few signaling.
Signal Transduction G-Proteins Phosphotidyl Inositol Tyrosine Kinase.
Basic Concepts of Metabolism
Cell Signalling. Figure source: uk/teaching/courses/mo dules/Ercs.html Figure source: uk/teaching/courses/mo.
Chap. 15 Problem 2 Signaling systems are classified based on the distance over which they act. Endocrine signaling acts over long distances within the.
Bear et al. 2001, Neuroscience, 2nd ed. The Impact of Neurotransmitters Metabotropic Receptors.
Signal Transduction and Secondary Messengers Mahmoud Farhat.
Cell Signaling (BIO-203) Lecture 5. Signal amplification occurs in many signaling pathways Receptors are low abundance proteins The binding of few signaling.
Chapter 14. Signal Transduction Signal transduction is the process by which an extracellular signal alters intracellular events. 1. First and second messengers.
Pancreatic Alpha & Beta Cells Pancreatic Alpha & Beta Cells BCMP234 Cell of the Week Jessica Spinelli 02/01/16.
TARGETS FOR G-PROTEINS The main targets for G-proteins, through which GPCRs control different aspects of cell function are: adenylyl cyclase, the enzyme.
Pharmacodynamics III Receptor Families
Ca2+ and phosphatidylinositol second messenger systems
G protein–coupled receptors
ION CHANNELS AS DRUG TARGETS & CONTROL OF RECEPTOR EXPRESSION
Figure 4. Two Intracellular Signaling Cascades Implicated in Chemosensory Transduction(A) Diagram of cyclic nucleotide signaling in the transduction compartment.
Figure 2 Pathophysiology of hyperglycaemia in T2DM
Regulation of platelet plug formation by phosphoinositide metabolism
Figure 4 Amino acid structure of short-acting and long-acting insulins
Insulin Domina Petric, MD.
Temporal Bias: Time-Encoded Dynamic GPCR Signaling
Inositol as putative integrative treatment for PCOS
Choosing glucose-lowering medication in those with established ASCVD, HF, and CKD. CV, cardiovascular; DPP-4i, dipeptidyl peptidase 4 inhibitor; GLP-1.
Insulin Secretion: Fatty Acid Signalling via Serpentine Receptors
Membrane Dynamics 5.
The Incretins and β-Cell Health: Contrasting Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 as a Path to Understand Islet Function.
Figure 2 Candidate signalling pathways of irisin in myocytess
Figure 3 Putative actions of glucagon-like peptide 1 (GLP-1)
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 The sensory and secretory function of the L cell
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
ION CHANNELS AS DRUG TARGETS &
Signal transduction and hepatocellular bile acid transport: Cross talk between bile acids and second messengers  Bernard Bouscarel, Spencer D. Kroll,
Figure 3 Polysaccharides from plants and mushrooms
Figure 2 Oestrogen receptor signalling pathways
Figure 2 Intracellular actions of metformin
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 3 Integrative signalling networks enable interactions
Figure 4 Effects of glucagon-like peptide 1 (GLP-1) and
Figure 2 Molecular mechanisms of the antidiabetic
A or alpha cells, secrete glucagon. B or beta cells, secrete insulin. The pancreas is a two different organs contained within one structure:-  Exocrine.
Nat. Rev. Endocrinol. doi: /nrendo
Insulin and Glucagon Kamilah Gonzalez.
Nat. Rev. Endocrinol. doi: /nrendo
Integration of Satiety Signals by the Central Nervous System
Diabetes Mellitus and the β Cell: The Last Ten Years
Nat. Rev. Endocrinol. doi: /nrendo
TCF7L2 ChIP-seq in HCT116 cells.
Nat. Rev. Nephrol. doi: /nrneph
Mark S Taylor, A.Marie McMahon, Jason D Gardner, Joseph N Benoit 
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 Sites of action of glucose-lowering agents
Estrogen Receptors and the Metabolic Network
The HETE Is on FFAR1 and Pancreatic Islet Cells
Temporal Bias: Time-Encoded Dynamic GPCR Signaling
Figure 1 Exercise enhances insulin sensitivity
Figure 1 Altered modes of cAMP signalling at PTHR1
Model for the regulation of insulin secretion in the β-cell stimulated by glucose and amino acids. Model for the regulation of insulin secretion in the.
Collecting new targets in MODY
Linking Calcium to Aβ and Alzheimer's Disease
Chemoreception: Tasting the sweet and the bitter
Signaling pathways of galanin receptors.
Ringing the dinner bell for insulin: Muscarinic M3 receptor activity in the control of pancreatic β cell function  Jesper Gromada, Thomas E. Hughes  Cell.
Presentation transcript:

Nat. Rev. Endocrinol. doi:10.1038/nrendo.2016.86 Figure 3 Sulfonylureas, meglitinides and glucagon-like peptide 1 receptor agonists (GLP‑1RAs) act on pancreatic β cells to increase nutrient-induced insulin secretion Figure 3 | Sulfonylureas, meglitinides and glucagon-like peptide 1 receptor agonists (GLP-1RAs) act on pancreatic β cells to increase nutrient-induced insulin secretion. These agents bind to the cytosolic surface of the sulfonylurea receptor 1 (SUR1), which is part of the ATP-sensitive Kir6.2 potassium channel. Binding of the sulfonylurea or meglitinide closes the Kir6.2 channel, preventing potassium efflux and thereby depolarizing the plasma membrane. Depolarization opens local voltage-dependent calcium channels, increasing the influx of calcium and activating calcium-dependent signalling proteins that control insulin exocytosis. GLP-1RAs enhance nutrient-induced insulin release mainly via a cAMP–EPAC2-mediated potentiation of granule exocytosis. DAG, diacylglycerol; EPAC2, rap guanine nucleotide exchange factor 4; GLUT, glucose transporter isoform; IP3, inositol-1,4,5-trisphosphate; Rap1, Ras-related protein 1; PKA, protein kinase A; PKC, protein kinase C; PLC, phospholipase C. Tahrani, A. A. et al. (2016) Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus Nat. Rev. Endocrinol. doi:10.1038/nrendo.2016.86